Rectal Disease Spectrum (rectum Cancer Progression) Tissue Array, 75 Cases/80 Cores|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173860

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Rectal Disease Spectrum (rectum Cancer Progression) Tissue Array, 75 Cases/80 Cores)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2025年04月29日 20時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Human Rectal disease spectrum(rectum cancer progression) tissue array, 75 cases/80 cores
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2025年04月29日 20時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Human Rectal disease spectrum(rectum cancer progression) tissue array, 75 cases/80 cores

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Rectum disease spectrum (rectal carcinoma progression) tissue microarray, containing 10 cases of rectal metastatic carcinoma, 24 adenocarcinoma, 4 squamous cell carcinoma, 10 adenoma, 1 undifferentiated carcinoma, 6 polyp, 10 hyperplasia, 5 each of rectal inflammation, adjacent normal tissue and normal rectal tissue, single core per case
Cores: 80
組織アレイ
Cases: 75
Layout: 10 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 36 Lympy node Metastatic adenocarcinoma of mesentery from rectum 1 Metastasis
A2 2 M 45 Lympy node Metastatic adenocarcinoma of mesentery from rectum 2 Metastasis
A3 3 M 38 Lympy node Metastatic adenocarcinoma of mesentery from rectum 2 Metastasis
A4 4 F 38 Lympy node Metastatic adenocarcinoma of mesentery from rectum 2 Metastasis
A5 5 F 48 Lympy node Metastatic adenocarcinoma of mesentery from rectum 2 Metastasis
A6 6 M 41 Lympy node Metastatic mucinous adenocarcinoma of mesentery from rectum 2–3 Metastasis
A7 7 M 51 Lympy node Metastatic adenocarcinoma of omentum from rectum 3 Metastasis
A8 8 F 50 Lympy node Metastatic mucinous adenocarcinoma of mesentery from rectum 3 Metastasis
A9 9 F 35 Mesentery Metastatic mucinous adenocarcinoma from rectum 3 Metastasis
A10 10 F 46 Lympy node Metastatic mucinous adenocarcinoma of mesentery from rectum 3 Metastasis
B1 11 M 36 Rectum Adenocarcinoma 1 II T3N1M0 Malignant
B2 12 M 61 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
B3 13 F 54 Rectum Adenocarcinoma 1 I T1N0M0 Malignant
B4 14 M 70 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
B5 15 M 53 Rectum Adenocarcinoma 2 III T4N1M0 Malignant
B6 16 M 49 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
B7 17 M 60 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
B8 18 F 47 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
B9 19 F 52 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
B10 20 M 60 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
C1 21 M 70 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
C2 22 M 64 Rectum Adenocarcinoma 2 I T2N0M0 Malignant
C3 23 M 60 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
C4 24 M 82 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
C5 25 M 40 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
C6 26 F 60 Rectum Adenocarcinoma 3 II T4N0M0 Malignant
C7 27 F 48 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
C8 28 F 62 Rectum Mucinous adenocarcinoma 2 I T1N0M0 Malignant
C9 29 F 45 Rectum Adenocarcinoma 3 I T2N0M0 Malignant
C10 30 M 61 Rectum Adenocarcinoma 3 II T4N0M0 Malignant
D1 31 M 51 Rectum Adenocarcinoma 3 II T4N0M0 Malignant
D2 32 F 46 Rectum Adenocarcinoma 3 II T3N0M0 Malignant
D3 33 M 40 Rectum Adenocarcinoma 2–3 I T2N0M0 Malignant
D4 34 M 40 Rectum Signet-ring cell carcinoma II T4N0M0 Malignant
D5 35 M 64 Rectum Squamous cell carcinoma 1 I T2N0M0 Malignant
D6 36 F 76 Rectum Squamous cell carcinoma (sparse) II T4N0M0 Malignant
D7 37 F 53 Rectum Squamous cell carcinoma 1–2 I T2N0M0 Malignant
D8 38 F 50 Rectum Squamous cell carcinoma 3 II T3N1M0 Malignant
D9 39 M 62 Rectum Villous adenoma Benign
D10 40 M 57 Rectum Villous adenoma Benign
E1 41 M 38 Rectum Tubular adenoma Benign
E2 42 F 62 Rectum Tubulovillous adenoma Benign
E3 43 F 47 Rectum Tubulovillous adenoma Benign
E4 44 M 49 Rectum Tubular adenoma Benign
E5 45 F 60 Rectum Villous adenoma Benign
E6 46 M 73 Rectum Villous adenoma Benign
E7 47 F 38 Rectum Villous adenoma Benign
E8 48 M 70 Rectum Villous adenoma Benign
E9 49 F 58 Rectum Undifferentiated carcinoma Malignant
E10 50 F 34 Rectum Hyperplastic polyp Polyp
F1 51 M 75 Rectum Hyperplastic polyp Polyp
F2 52 F 33 Rectum Inflammatory polyp Polyp
F3 53 M 4 Rectum Inflammatory polyp Polyp
F4 54 M 3 Rectum Inflammatory polyp Polyp
F5 55 F 10 Rectum Juvenile polyp Polyp
F6 56 M 50 Rectum Adenomatoid hyperplasia Hyperplasia
F7 57 F 47 Rectum Chronic inflammation of rectal mucosa with hyperplasia of gland Hyperplasia
F8 58 M 89 Rectum Adenomatoid hyperplasia Hyperplasia
F9 59 F 40 Rectum Hyperplasia (fibrofatty tissue and blood vessel) Hyperplasia
F10 60 F 42 Rectum Adenomatoid hyperplasia Hyperplasia
G1 61 F 54 Rectum Adenomatoid hyperplasia Hyperplasia
G2 62 M 40 Rectum Chronic inflammation of rectal mucosa with hyperplasia of gland Hyperplasia
G3 63 M 62 Rectum Chronic inflammation of rectal mucosa with mild atypical hyperplasia of gland Hyperplasia
G4 64 M 79 Rectum Chronic inflammation of rectal mucosa with moderate atypical hyperplasia of gland Hyperplasia
G5 65 F 76 Rectum Chronic inflammation of rectal mucosa with severe atypical hyperplasia of gland Hyperplasia
G6 66 F 72 Rectum Chronic inflammation of mucosa Inflammation
G7 67 M 70 Rectum Chronic inflammation of mucosa of No. 14 Inflammation
G8 68 M 53 Rectum Chronic inflammation of mucosa of No. 15 Inflammation
G9 69 M 70 Rectum Chronic inflammation of mucosa of No. 21 Inflammation
G10 70 F 60 Rectum Chronic inflammation of mucosa of No. 26 Inflammation
H1 71 M 60 Rectum Cancer adjacent normal rectal tissue (chronic inflammation of rectal mucosa) of No. 20 NAT
H2 72 F 52 Rectum Cancer adjacent normal rectal tissue NAT
H3 73 M 43 Rectum Cancer adjacent normal rectal tissue NAT
H4 74 M 60 Rectum Cancer adjacent normal rectal tissue NAT
H5 75 F 50 Rectum Cancer adjacent normal rectal tissue NAT
H6 76 M 45 Rectum Normal rectal tissue Normal
H7 77 M 50 Rectum Normal rectal tissue Normal
H8 78 F 21 Rectum Normal rectal tissue Normal
H9 79 F 41 Rectum Normal rectal tissue Normal
H10 80 M 28 Rectum Normal rectal tissue Normal
M 58 Skin Malignant melanoma (tissue marker) Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。